-
AdventHealth's artificial intelligence chief aims to cut through the 'uncertainty' of AI in healthcare
February 25, 2025
AdventHealth has appointed Rob Purinton as its first chief artificial intelligence officer, a newly created role aimed at reducing uncertainty around AI while guiding the health system's overall strategy for using the technology.
He was recently interviewed by Becker’s Hospital Review about how he is implementing a robust, risk-based governance framework for AI.
-
AdventHealth leans into 'whole-person' cancer care
February 25, 2025
The newly opened AdventHealth Cancer Institute Winter Park was designed with more than radiation and immunotherapy in mind.
Alongside a Varian TrueBeam Linear Accelerator, patients will find a boutique spa where their hair loss, lymphedema and mastectomy concerns can be addressed, and a financial counselor to help them navigate the monetary stresses of cancer care.
Rajesh Sehgal, MD, director of oncology at AdventHealth Cancer Institute Winter Park, spoke with Becker's about why this care strategy is so crucial for cancer patients.
-
Whole-person care extends home with launch of AdventHealth Hospital at Home
February 25, 2025
Patients in Central Florida now have the option to receive hospital-level acute health care at home with AdventHealth Hospital at Home. The program enables patients who would have required an inpatient stay at the facility to receive care at home instead.
-
3 Ways to Stay Competitive in Cardiology, according to an AdventHealth Leader
October 24, 2024
The "dichotomy" of great leaders, being more than transactional and creating a meaningful work environment are just three ways Gordon Wesley, DBA, vice president at AdventHealth’s Heart, Lung and Vascular Institute is leading the industry with his cardiology program.
Dr. Wesley was recently interviewed by Becker’s Hospital Review about how organizations cannot thrive without great leadership, and how that impacts both patients and providers.
-
What's Missing in Cardiology Conversations
October 24, 2024
From preparing for the effects of AI to anticipating the "silver tsunami," cardiology leaders, including Gordon Wesley, Vice President of the AdventHealth Heart, Lung, and Vascular Institute, shared their insights with Becker's Hospital Review on what should be key topics of conversation within the industry.
-
AdventHealth Physician, Team Pioneer Endoscopic Procedure Allowing Patient to Eat Again
August 16, 2024
The American Hospital Association’s Center for Health Innovation recently highlighted gastroenterologist Kamibiz Kadkhodayan, MD and his team at AdventHealth’s Center for Interventional Endoscopy.
Dr. Kadkhodayan was the first in the world to develop and perform a brand-new procedure, endoscopic blind limb reduction with septotomy — dubbed the “candy cane” procedure — which allowed a gastric bypass patient who could only receive intermittent nourishment through an IV to eat solid food again.
-
Boosting Infection Prevention: A Case Study on AdventHealth Celebration
July 31, 2024
According to according to Alric Simmonds, MD, vice president and chief medical officer of AdventHealth Celebration and chief health equity officer for AdventHealth, the decision to amplify the infection prevention and control staff at AdventHealth Celebration has yielded multitude of benefits.
Voice for Infection Prevention breaks down how the impactful measures have contributed positively towards clinical outcomes at the hospital.
-
AdventHealth Infection Preventionist Successfully Advocates for Staff Growth, Keeping Pace with Hospital’s Expanding Service Lines
July 31, 2024
The Association for Professionals in Infection Control and Epidemiology also recently highlighted how AdventHealth Celebration leadership reduced infections and created opportunities for non-clinical team members to enter the field and excel.
Luz Caicedo explained how she also created an IPC career ladder with diversified roles, outlining career progression and enhancing retention among the team.
-
Another One for Ozempic? Investigator Recounts Trial for Chronic Kidney Disease
July 29, 2024
Richard Pratley, MD, senior investigator, AdventHealth Translational Research Institute, is the senior author on a recent study published in the New England Journal of Medicine that explores the benefits of Ozempic in Type 2 diabetes patients with chronic kidney disease. The Phase 3 study, called FLOW, evaluated the efficacy and safety of Ozempic in people with T2D and chronic kidney disease in preventing kidney failure, substantial loss of kidney function, and death from kidney or cardiovascular causes. Results indicate that the drug “reduced the risk of clinically important kidney outcomes and death from cardiovascular causes.”
Clinical Leader recently chatted with Dr. Pratley about his positive experience working with Novo Nordisk and the challenges of executing the trial amid the COVID-19 pandemic and changing standard-of-care landscape.
-
Insights into AdventHealth’s ACCESS-T1D Study
June 28, 2024
On the Becker’s Healthcare Podcast, Dr. Anna Casu, Researcher at AdventHealth Research Institute, provides insights into AdventHealth’s ACCESS-T1D study, emphasizing the importance of expanding screening for Type 1 diabetes.
She also shares her background and personal journey with Type 1 diabetes.
-
New Evidence for a ‘Thrifty’ Microbiome in Humans
June 27, 2024
June 27 is World Microbiome Day, providing an opportunity for researchers, industry professionals and the public to come together in discussion and debate on the influence of microbes and microbiomes on the health of humans, animals, plants, oceans and the planet.
Springer Nature Journals highlighted work at the AdventHealth Translational Research Institute around the ‘thrifty’ microbiome and the potential for fermented food to impact weight loss or gain.
-
Health Care Outcomes When Hospitals Embrace Vertical Farming
June 27, 2024
AdventHealth recognized the importance of nutrition in whole-person care and saw the opportunity to provide their team members, physicians, patients and the public with fresh, nutritious food and donate to local food pantries.
Dr. Amber Orman, Chief Wellness Officer at AdventHealth, and Rick Vanzura, CEO of Freight Farms discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities on the Empowered Patient podcast.
-
From the Bedside to CEO: One AdventHealth’s Leader Unique Journey to the Boardroom
May 14, 2024
While many hospital CEOs come from backgrounds in business, finance, or health care administration, there's a small but impactful percentage who began their careers as nurses, caring for patients at the bedside.
Audrey Gregory, Ph.D., RN, executive vice president and CEO of the AdventHealth East Florida Division, recently shared her journey – along with six other leaders who also made the journey from the clinical frontlines to the boardroom – with Florida Trend’s Mike Brassfield.
-
AdventHealth Leaders Honored on Nationwide List of Exceptional Chief Medical Officers
April 18, 2024
Victor Herrera, MD, Senior Vice President and Chief Clinical Officer for AdventHealth’s Central Florida Division and Stephen Knych, MD, Chief Medical Officer at AdventHealth East Florida Division and AdventHealth Fish Memorial were named to Becker’s Healthcare’s list of 180 chief medical officers to know.
-
Gut Health Cautions
February 23, 2024
Karen Corbin, Ph.D., an investigator at the AdventHealth Research Institute of Metabolism and Diabetes, recently spoke with The Atlantic about claims certain foods and products can overhaul gut health and guarantee overall well-being.
-
A Window on Risk
February 20, 2024
Florida Trend highlights an AdventHealth pilot program that aims to get an early handle on heart disease and other health issues unmasked by pregnancy.
-
Use Less, Lose Less, Hire More.
February 7, 2024
Trish Celano, chief nursing officer for AdventHealth, joins the Becker’s Healthcare Clinical Leadership Podcast to discuss current nursing programs and initiatives at AdventHealth she is excited about, plans for workforce retention, key insights into her background and organization and more.
-
Artificial Intelligence’s Potential in Health Care
January 30, 2024
Dr. Victor Herrera, senior vice president and chief clinical officer, AdventHealth Central Florida and Rob Purinton, vice president of clinical analytics and performance improvement at AdventHealth were recently featured on the Synapse Innovation Podcast to talk about Artificial Intelligence in health care.
They discussed the potential impacts AI can have on health care, the ways the technology can bridge gaps in the patient care process and how AdventHealth’s AI advisory board ensures AI is used ethically.
-
AdventHealth for Children Recognized by Becker’s Hospital Review for Psychiatry and Mental Health Programs
January 19, 2024
Becker’s Hospital Review recently named a list of 36 hospitals and health systems for their robust psychiatry and mental health programs, saying they understand mental health is just as integral to overall wellbeing as physical health, and provide services that support patients' psychiatric, emotional and behavioral needs.
Becker’s went on to say these programs blend medication, education, therapy and novel treatment methods to address this critical yet often overlooked healthcare demand.
-
What Excites 101 Health System Executives for the Next Year
January 18, 2024
Becker's Hospital Review asked C-suite executives from hospitals and health systems across the U.S. to share their organization's areas of growth for the next few years. Brian Adams, President and CEO of AdventHealth Central Florida Division, shared his focus for 2024.
-
AdventHealth University, Orlando College of Osteopathic Medicine Move Closer to New School Opening this Year
January 18, 2024
Spectrum News 13 spoke with leaders from AdventHealth University, the Orlando College of Osteopathic Medicine and potential students about work to build a new school in Orange County designed to fill the growing demand for physicians.
-
AdventHealth Physician and Team Become First in the World to Create and Perform New Endoscopic Procedure
December 19, 2023
Dr. Kambiz Kadkhodayan discusses his background and work creating a brand-new procedure called an Endoscopic Blind Limb Reduction with Septotomy, also known as a “Candy Cane” procedure, his opinion on GLP-1 weight-loss drugs and more.
-
Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma
December 19, 2023
Dr. Guru Sonpavde discusses his recent NEJM paper on a Phase 3 trial tied to GU cancer and the drug combo of chemotherapy and immunotherapy improving durable complete remission rates to ~22% from ~12%, what he’s most focused on and excited about in the next 3-5 years, advice for evolving researchers and more.
-
Dr. Mark Socinski on the Heterogeneity of Lung Cancer and Targeted Treatment
December 7, 2023
In an interview with the American Journal of Managed Care, Dr. Mark Socinski, executive director at AdventHealth Cancer Institute, explained how the understanding of lung cancer has evolved in recent years, as well as how the heterogeneity of the disease impacts treatment decisions.
-
A Discussion on the Impacts of Immunotherapy on Lung Cancer Outcomes
December 7, 2023
Mark Socinski, MD, executive director at AdventHealth Cancer Institute, also discussed the impacts of immunotherapy on outcomes for certain patients with non–small cell lung cancer with the American Journal of Managed Care.
-
9 Recruitment and Retention Strategies for Physicians and Advanced Practice Providers
December 1, 2023
The physician employment market across the country is tighter than ever, with demand outstripping supply in many specialties. As a result, CMOs are turning to advanced practice providers (APPs) to supplement their physician staff.
Dr. Eric Deshaies, chief physician executive of AdventHealth Medical Group, recently explained how health systems must adopt a multitude of recruitment and retention strategies for physicians and advanced practice providers (APPs).
-
AdventHealth Researcher Could Help Doctors Prescribe the Right Exercise to Battle Dementia
November 30, 2023
Physical exercise is good for our brains as we age.
But why is that? What's the right amount to deter dementias like Alzheimer's disease? And why do some seniors stay the course and others don't?
Kirk Erickson, Ph.D., the director of translational neuroscience at the AdventHealth Research Institute, is coordinating a major study to answer those questions.
-
Dr. Daryl Osbahr on Advancing ACL Restoration Surgery with AdventHealth and Rothman Orthopaedic Institute
October 23, 2023
AdventHealth, in partnership with Rothman Orthopaedic Institute, became the first facility to complete 100 surgeries with the bridge-enhanced ACL restoration implant.
Daryl Osbahr, MD, executive medical director for the AdventHealth Orthopedic Institute and a Rothman surgeon, completed the majority of those BEAR cases. He spoke with Becker's about his journey with the procedure.
-
How Executives are Preparing for the Workforce of the Future
October 16, 2023
A new employment study found health care employment has risen since the start of the COVID-19 pandemic in February 2020.
The changing dynamics and trends prompted Becker’s Hospital Review to ask health system executives: What do you envision the healthcare workforce will look like in five years in terms of composition and shortages? How is your organization preparing?
Associate Chief People Officer Amy Santorelli talks about why flexibility will be important to AdventHealth’s workforce for years to come.
-
Orlando Boy Among First in the World to Receive Life-Changing Type 1 Diabetes Drug
October 11, 2023
Orlando is on the map when it comes to a new drug giving hope to people with type 1 diabetes. Dr. Konda Reddy spoke with FOX 35’s Amy Kaufeldt about one young patient who is among the first in the world to receive the drug.
-
Seeking Better Treatment for Children with Cancer
October 2, 2023
Pediatric cancer is the leading cause of death by disease for children in the United States. Dr. Brian Tullius spoke with News 6 about the work underway at AdventHealth to develop more effective and tolerable treatments.
-
Oncolytic Viral Immunochemotherapy in Patients with Ovarian Cancer
September 19, 2023
Dr. Robert Holloway discusses his research recently published in JAMA outlining how patients with platinum-resistant or platinum-refractory ovarian cancer (PRROC) have limited therapeutic options, representing a considerable unmet medical need.
-
New Research on Healthy Aging and Lifestyle Versus Genetics
September 7, 2023
Bret Goodpaster, PhD discusses research being conducted at AdventHealth’s Translational Research Institute that aims to examine how well we age and how to help mature adults get the most out of life.
-
New Study Shows Breast, Colon and Pancreatic Cancer Rates Rising in Young Adults
September 6, 2023
Dr. Mohamedtaki Tejani and Dr. Amber Orman discuss a new JAMA study that shows breast, colon and pancreatic cancer rates increasing at concerning rates among America's young adults, why they believe this trend of seeing younger patients is happening, how lifestyle plays into higher rates, what can be done to decrease risk, and more.
-
New Research Sheds Light on Improved Lung Cancer Survival Rates
August 23, 2023
Dr. Mark Socinski discusses his new research recently published in JAMA that finds having an inflammatory side effect with advanced non-small cell lung cancer (NSCLC) might not be such a bad thing, how this research can help with survival rates and if this may extend into other areas of cancer.
-
Powerful New Study Demonstrates a HER-2 Targeted Therapy is Effective in a Rare Tumor Type
August 18, 2023
Dr. Mohamedtaki Tejan says the key takeaway from this study is that it is critical for patients with biliary tract cancer to have molecular tumor profiling right at diagnosis.
-
How Diet Can Affect the Gut Microbiome
August 7, 2023
On a recent episode of ReachMD's Diabetes Discourse podcast, Karen Corbin, PhD, provides a detailed overview of a study understanding how the gut microbiome can be involved in regulating weight and metabolic health. She also explores where research being done at AdventHealth's Translational Research Institute may go next.
-
Reflecting on a Decade of Discovery
June 20, 2023
Dr. Steven Smith looks back on a decade of world-class, innovative research being performed at AdventHealth's Translational Institute and what the future could hold.
-
In NSCLC, Biomarker Testing Is Key to Treating Patients Properly
April 28, 2023
Dr. Mark Socinski discusses why cancer is a disease of your DNA and how it can be treated in non-small cell lung cancer (NSCLC) patients.
-
Novel Detection Methods May End Chemotherapy for Patients With CRC
April 19, 2023
Dr. Tejani discusses a new genetic test that may allow patients with colorectal cancer to avoid chemotherapy after tumor resection.
-
How Does Physical Activity Affect Brain and Cognitive Function
April 18, 2023
Join Dr. Kirk Erickson as he discusses in depth how physical activity affects the brain in this global podcast.
-
Florida Medical Association President tours AdventHealth Mission Control
April 2023
Take a behind-the-scenes tour of the largest healthcare command center in the U.S. with FMA president and Dr. Sanjay Pattani.
-
Long COVID: Preparing for the Next Major Chronic Illness
March 8, 2023
AdventHealth physicians share how the Post-COVID Clinic operates, the improvements in patient outcomes and their first year of research findings in an American Hospital Association podcast.
-
AdventHealth Chief Clinical Officer reflects on three decades of leadership
Feb. 18, 2023
Neil Finkler, M.D., reflects on his three decades with AdventHealth as he retires and shares his hopes for clinicians in the future.
-
A multi-disciplinary team approach to childhood obesity
Feb. 16, 2022
Dr. Angela Fals reflects on the past 12 years of the pediatric weight management program at AdventHealth for Children, provides insight on how to launch and operate this type of program, and emphasizes the relationships with pediatricians and sub-specialist colleagues in the community.
-
AdventHealth part of new FDA-approved drug to delay onset of Type 1 diabetes
Jan. 29, 2023
Anna Casu, M.D. explains the work AdventHealth is doing with Tzield, the first and only FDA-approved drug to delay the onset of Type 1 diabetes.
-
Mitigating Colorectal Cancer Treatment Risks Through ctDNA Testing
Jan. 9, 2023
Mohamedtaki Tejani, MD, director of GI Oncology at AdventHealth, discusses how many risks associated with chemotherapy may be mitigated by incorporating ctDNA testing into medical decisions for colorectal cancer patients.
-
Exercise-mimicking drugs boost brain health
Jan. 5, 2023
Exercise-induced molecules may inspire the next generation of neuroprotective drugs, according to Kirk Erickson, Ph.D.
-
The Exec: Chief Clinical Officer makes predictions for 2023
Dec. 28, 2022
AdventHealth's Neil Finkler, M.D., predicts healthcare workforce shortages will spur adoption of technology such as artificial intelligence and machine learning.
-
Disordered eating, insulin restriction reduces beneficial gut microbes
Dec. 19, 2022
Disordered eating and insulin restriction were associated with a reduced abundance of short-chain fatty acid-producing gut microbes explains Daria Igudesman, Ph.D. at the AdventHealth Translational Research Institute.
-
The Healing Power of Music: How AdventHealth Staff Formed an Orchestra During the Pandemic
Dec. 8, 2022
Vincent Hsu, M.D. shares his personal story performing with colleagues in the AdventHealth Orchestra and how it helped improve his well-being during the challenges during the pandemic.
-
AdventHealth Participating in Groundbreaking Alzheimer’s Disease Research
Dec. 8, 2022
AdventHealth is one of two sites in the U.S. and one of seven in the world to partner with the Davos Alzheimer’s Collaborative (DAC) and participate in groundbreaking research to measurably increase rates of cognitive screening, early detection, and accurate diagnosis of Alzheimer’s disease.
-
New Commercially Available PCR Test Detects 3 Brain-Eating Amoebas in 3 Hours
Nov. 16, 2022
AdventHealth physician develops new commercially available PCR test can detect three common brain-eating amoebas in three hours: Naegleria fowleri, Balamuthia mandrillaris, and Acanthamoeba spp.
-
How a Data-Driven Command Center Can Improve ED Outcomes
Nov. 8, 2022
AdventHealth's data-driven Mission Control Command Center is allowing the health system to improve emergency department outcomes through bed capacity management.
-
AdventHealth criticizes organ transplant system
Nov. 2, 2022
Leaders at AdventHealth, including Dr. Bobby Nibhanupudy, M.D., are calling for improvements in the U.S. organ transplant system.
-
AdventHealth ctDNA testing research underway for colorectal patients
Oct. 22, 2022
Dr. Mohamedtaki Tejani, Medical Director, GI Oncology Program at the AdventHealth Cancer Institute, explains three clinical trials underway at AdventHealth to evaluate the effectiveness and impact of different types of ctDNA testing for colorectal cancer patients.
-
AdventHealth physician first in Central Florida to use Anovo Surgical System
Oct. 15, 2022
Dr. Erica Stockwell recently made history by being the first in the hospital system to do a robotic gynecologic procedure on the new Anovo Surgical System.
-
AdventHealth among first in the U.S. to use new MITRIS RESILIA Bioprosthetic Mitral Replacement Valve
Oct. 15, 2022
AdventHealth Orlando Cardiovascular Surgeon Kevin Accola, M.D., participated in the COMMENCE pre-market clinical trial to evaluate the new MITRIS valve's safety and effectiveness.
-
AdventHealth creates new brain-eating amoeba detection test
Oct. 14, 2022
AdventHealth physician Jose Alexander, M.D. discusses his focus on brain-eating amoebas & how he and his team were able to use protocols from COVID-19 to better the testing & treatment for those infected.
-
New AdventHealth clinic focuses on treating patients with long COVID-19
Oct. 12, 2022
AdventHealth opens a new clinic aimed at treating long COVID-19 patients and Dwayne Gordon, M.D. talks about what symptoms we're seeing in our patients as well as the research involved to gain a better understanding of how COVID interacts with the human body.
-
AdventHealth using 'mission control' center to improve care coordination metrics
Sept. 28, 2022
AdventHealth is using a command center it calls "mission control" to improve its care coordination metrics and Sanjay Pattani, M.D., emergency medicine physician and associate chief medical officer of AdventHealth Mission Control, explains more.
-
How the Current Organ Transplant System Failed Patients and Providers
Sept. 27, 2022
The current organ transplant system and its methods for organ allocations have caused conflicts and failed providers and patients, explains Dr. Bobby Nibhanupudy, M.D. medical director of the abdominal transplant program at AdventHealth.